Stage III Ovarian Epithelial Cancer [clinicaltrials_resource:3e19aa858a2ba504f71f84596bb729c6]
Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer [clinicaltrials:NCT00002913]Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu [clinicaltrials:NCT00004074]Bryostatin 1 and Cisplatin in Treating Patients With Advanced Recurrent or Residual Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [clinicaltrials:NCT00006942]Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer [clinicaltrials:NCT00011986]Imatinib Mesylate in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer [clinicaltrials:NCT00036751]clinicaltrials:NCT00041080Combination Chemotherapy Plus Erlotinib in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [clinicaltrials:NCT00059787]Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer [clinicaltrials:NCT00060372]Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [clinicaltrials:NCT00079430]3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer [clinicaltrials:NCT00081276]Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) [clinicaltrials:NCT00085358]EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer [clinicaltrials:NCT00087191]Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors [clinicaltrials:NCT00089362]clinicaltrials:NCT00093496EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer [clinicaltrials:NCT00107445]Ixabepilone and Liposomal Doxorubicin in Treating Women With Advanced Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer or Metastatic Breast Cancer [clinicaltrials:NCT00182767]Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors [clinicaltrials:NCT00301756]clinicaltrials:NCT00357448clinicaltrials:NCT00390234Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00408655]Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease After Donor Stem Cell Transplant [clinicaltrials:NCT00408681]Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer [clinicaltrials:NCT00436254]Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy [clinicaltrials:NCT00466960]Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant [clinicaltrials:NCT00795769]clinicaltrials:NCT01079832Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) [clinicaltrials:NCT01126346]clinicaltrials:NCT01155258clinicaltrials:NCT01159067Vaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian Cancer [clinicaltrials:NCT01322802]Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant [clinicaltrials:NCT01558778]
condition [clinicaltrials_vocabulary:condition]
Stage III Ovarian Epithelial Cancer [clinicaltrials_resource:3e19aa858a2ba504f71f84596bb729c6]
Bio2RDF identifier
3e19aa858a2ba504f71f84596bb729c6
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3e19aa858a2ba504f71f84596bb729c6
identifier
clinicaltrials_resource:3e19aa858a2ba504f71f84596bb729c6
title
Stage III Ovarian Epithelial Cancer
@en
label
Stage III Ovarian Epithelial C ...... 9aa858a2ba504f71f84596bb729c6]
@en